- Proclinic expects its turnover to reach more than €220m this year
- Some 35% of that will come from international activity
- Miura invested in Proclinic via an MBO in 2021
Miura Partners-backed Proclinic Group has bought Meditrans, a distributor of dental products and services in Poland, the firms announced on Tuesday.
Proclinic expects the acquisition of Kielce-based Meditrans to push its turnover to more than €220 million this year, with more than 35 percent of that coming from international activity. Meditrans distributes 20 percent of the dental consumables market in Poland.
Zaragoza-headquartered Proclinic is an integrated supplier of products for the dental sector in Spain, with nearly 100,000 product references and presence in 31 countries. The purchase of Meditrans will grow its portfolio of products and help consolidate its presence in central Europe, especially in Germany and Poland, the firm said, and add new e-commerce to its digital platforms.
Miura Partners is a private equity firm headquartered in Barcelona with offices in Madrid. It focuses on investments in small- and medium-sized family-owned and entrepreneurial businesses in southern Europe. It invested in Proclinic via a management buyout in 2021.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: 
